Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 15547095.
- Also identified by PMC identifier 1754866.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate telomerase activity as a marker of lymphocyte proliferation in systemic lupus erythematosus (SLE). CD19+, CD4+, and CD8+ lymphocytes were isolated from the peripheral blood of nine patients with SLE and nine healthy controls by means of magnetic bead-coupled antibodies and tested for telomerase activity with the TRAP assay. Telomerase activity was significantly increased in CD19+ B cells from patients with SLE. CD4+ and CD8+ T cells from lupus patients displayed increased mean telomerase activity, although the difference from normal controls did not reach statistical significance. Increased telomerase activity in the B and the T cell lineage might indicate activation and proliferation of these lymphocytes.
Medical subject headings
- B-Lymphocyte Subsets
- Lupus Erythematosus, Systemic
- T-Lymphocyte Subsets
- Telomerase